Malcolm Salter - Sep 17, 2021 Form 4 Insider Report for C4 Therapeutics, Inc. (CCCC)

Role
Director
Signature
/s/ Shoaib Ghias, Attorney-in-Fact
Stock symbol
CCCC
Transactions as of
Sep 17, 2021
Transactions value $
-$37,667
Form type
4
Date filed
9/21/2021, 07:25 PM
Previous filing
Aug 24, 2021
Next filing
Oct 5, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCCC Common Stock Sale -$37.7K -755 -5.52% $49.89* 12.9K Sep 17, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on April 15, 2021.